Health

Ocrevus, or ocrelizumab, represents a significant advance in multiple sclerosis (MS) management, particularly for primary-progressive MS. By targeting B cells, it slows disease progression effectively. While highly beneficial, it requires a comprehensive approach that includes personalized care, complementary therapies, and continuous research into new treatments for optimal outcomes. The landscape of MS treatment is evolving, […]